Cargando…

A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant

A third dose of CVnCoV, a former candidate mRNA vaccine against SARS-CoV-2, was previously shown to boost neutralizing antibody responses against SARS-CoV-2 wild-type in adults aged 18–60 and >60 years in a phase 2a clinical study. In the present study, we report the neutralizing antibody respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolz, Olaf-Oliver, Kays, Sarah-Katharina, Junker, Helga, Koch, Sven D., Mann, Philipp, Quintini, Gianluca, von Eisenhart-Rothe, Philipp, Oostvogels, Lidia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025705/ https://www.ncbi.nlm.nih.gov/pubmed/35455257 http://dx.doi.org/10.3390/vaccines10040508

Ejemplares similares

Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study
por: Sáez-Llorens, Xavier, et al.
Publicado: (2022)

Corrigendum to “Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study” [Vaccine: X 11 (2022) 100189]
por: Sáez-Llorens, Xavier, et al.
Publicado: (2023)

A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses
por: Lenart, Klara, et al.
Publicado: (2022)

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
por: Kremsner, Peter G, et al.
Publicado: (2022)

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
por: Rauch, Susanne, et al.
Publicado: (2021)

CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2
por: Hoffmann, Donata, et al.
Publicado: (2021)

Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study
por: Ascaso-del-Rio, Ana, et al.
Publicado: (2022)

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial
por: Kremsner, Peter G., et al.
Publicado: (2021)

New BVR photometry of six prominent RS CVn binaries
por: Padmakar, et al.
Publicado: (1999)

Increased close proximity airborne transmission of the SARS-CoV-2 Delta variant()
por: Mikszewski, Alex, et al.
Publicado: (2022)

RS CVn vs. Algol-type binaries: a comparative study of their X-ray emission
por: Singh, K P, et al.
Publicado: (1996)

Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination
por: Bolze, Alexandre, et al.
Publicado: (2022)

Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
por: Kannan, Saathvik R., et al.
Publicado: (2021)

Structural evolution of Delta lineage of SARS-CoV-2
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2023)

SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera
por: Sahay, Rima R., et al.
Publicado: (2022)

Hold your horses: The receptor-binding domains of SARS-CoV-2, SARS-CoV, and hCoV-NL63 bind equine ACE2
por: Nawrath, Philipp, et al.
Publicado: (2022)

From Alpha to Delta—Genetic Epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland
por: Morawiec, Emilia, et al.
Publicado: (2022)

The cvn8 Conservon System Is a Global Regulator of Specialized Metabolism in Streptomyces coelicolor during Interspecies Interactions
por: Bonet, Bailey, et al.
Publicado: (2021)

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
por: Bager, Peter, et al.
Publicado: (2021)

Emergence of the Delta Plus variant of SARS-CoV-2 in Iran
por: Rahimi, Farid, et al.
Publicado: (2021)

SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
por: Meyerowitz, Eric A., et al.
Publicado: (2022)

Airborne transmission of the Delta variant of SARS-CoV-2 in an auditorium
por: Huang, Jianxiang, et al.
Publicado: (2022)

SARS-CoV-2 reinfections during the Delta and Omicron waves
por: Morris, C. Paul, et al.
Publicado: (2022)

Clinical and laboratory profiles of the SARS-CoV-2 Delta variant compared with pre-Delta variants()
por: Bhakta, Shivang, et al.
Publicado: (2022)

Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
por: Rockett, Rebecca J., et al.
Publicado: (2022)

Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR(7) Allosteric Agonist
por: Dickson, Louise, et al.
Publicado: (2023)

Multiple testing and the effect of NPIs on the spread of SARS-CoV-2
por: Rothe, Christoph
Publicado: (2021)

Clinical characteristics and severity of beta and delta variants of SARS-CoV-2 and the effect of vaccine on delta variants
por: Peng, Yahui, et al.
Publicado: (2022)

Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike – ACE2 complexes reveal distinct changes between both variants
por: Socher, Eileen, et al.
Publicado: (2022)

Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta
por: Fröba, Maria, et al.
Publicado: (2021)

The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus
por: Liu, Ying, et al.
Publicado: (2021)

The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants
por: Chen, Yuxin, et al.
Publicado: (2022)

SARS-CoV-2 Delta Variant among Asiatic Lions, India
por: Mishra, Anamika, et al.
Publicado: (2021)

Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster
por: Landsberg, Hannah E., et al.
Publicado: (2022)

Neutralisation de Sars-CoV-2 Delta après vaccination hétérologue
por: Manus, Jean-Marie
Publicado: (2021)

A focus on the spread of the delta variant of SARS-CoV-2 in India
por: Novelli, Giuseppe, et al.
Publicado: (2021)

SARS-CoV-2 antigen-detecting rapid tests for the delta variant
por: Bekliz, Meriem, et al.
Publicado: (2022)

Infection and pathogenesis of the Delta variant of SARS-CoV-2 in Rhesus macaque
por: Gao, Ge, et al.
Publicado: (2022)

Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia
por: Chang, Sheryl L., et al.
Publicado: (2022)

Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load
por: Migueres, Marion, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3rc5vmolv1spe4ohkf3o0aqobl